Abstract
Treatment with PCSK9 inhibitors in patients with familial hypercholesterolemia lowers plasma levels of platelet activating factor and its precursors: A combined metabolomic and lipidomic approach
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have